Westpac Banking Corp Neurocrine Biosciences Inc Transaction History
Westpac Banking Corp
- $1.49 Trillion
- Q3 2024
A detailed history of Westpac Banking Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Westpac Banking Corp holds 12,560 shares of NBIX stock, worth $1.8 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
12,560
Previous 6,390
96.56%
Holding current value
$1.8 Million
Previous $880 Million
64.5%
% of portfolio
0.1%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
632Shares Held
93.9MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.43 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$738 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$369 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$267 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...